Archive · 28 Jul 2026
Ebola outbreak reaches 3,200 cases as UK approves vaccine trial
The Ebola virus is spreading quickly in Africa, with over 3,200 people infected and 1,405 deaths.
The outbreak started in the Democratic Republic of the Congo (DRC) and has spread to other countries like Uganda.
Scientists are working hard to develop a vaccine for the rare Bundibugyo strain of Ebola.
The UK has approved the first human trial for this new vaccine, which uses similar technology to the COVID-19 vaccine.
The virus is mostly affecting the Ituri Province in the DRC, but it has spread to other regions as well.
Health officials are trying to contain the outbreak, but it's challenging because many cases are not linked to known contacts.
The vaccine trial is a big step forward in the fight against this deadly virus.
Ebola outbreak reaches over 3,200 cases, becoming the third-largest on record.
Outbreak originated in the Democratic Republic of the Congo (DRC) and spread to Uganda.
Over 1,400 deaths reported, with the virus primarily affecting the Ituri Province.
UK approves first human trial for a vaccine targeting the Bundibugyo strain of Ebola.
Vaccine uses technology similar to the Oxford-AstraZeneca COVID-19 vaccine.
- Who
- World Health Organization (WHO), UK's Medicines and Healthcare products Regulatory Agency (MHRA), Oxford University, Public Health Officials, Local Communities
- What
- Ebola outbreak caused by the Bundibugyo strain, human trial of a new vaccine approved
- When
- Outbreak began in May 2026, vaccine trial approved earlier this month
- Where
- Democratic Republic of the Congo (DRC), Uganda, Ituri Province
- Why
- To control the spread of the Ebola virus and develop effective treatments
Public Health Officials
Local Communities
Vaccine Development
Public Health Officials
Public health officials emphasize the importance of rapid vaccine development to control the outbreak.
Local Communities
Local communities express concerns about the safety and efficacy of new vaccines.
Outbreak Containment
Public Health Officials
Public health officials advocate for strict containment measures to prevent further spread.
Local Communities
Local communities resist strict measures due to economic and social disruptions.
- Total Cases
- 3,200
- Death Toll
- 1,405
- Outbreak Origin
- Democratic Republic of the Congo (DRC)
- Strain
- Bundibugyo
- Vaccine Trial
- Approved by UK's MHRA
- Primary Affected Region
- Ituri Province, DRC
- Vaccine Technology
- Similar to Oxford-AstraZeneca COVID-19 vaccine